Mavacoxib

Mavacoxib
Clinical data
Trade names Trocoxil
AHFS/Drugs.com International Drug Names
ATCvet code QM01AH92 (WHO)
Identifiers
CAS Number 170569-88-7
PubChem (CID) 9843089
ChemSpider 8018804
UNII YFT7X7SR77
ChEBI CHEBI:76207
Chemical and physical data
Formula C16H11F4N3O2S
Molar mass 385 g/mol
3D model (Jmol) Interactive image

Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.[1] It acts as a COX-2 inhibitor.[2]

References

  1. European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency
  2. Cox, S. R.; Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.; Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. (2010). "The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs". Journal of Veterinary Pharmacology and Therapeutics. 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.


This article is issued from Wikipedia - version of the 4/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.